Optional hypertension: a new concept emerging from trials of intensive blood pressure control ++++++

Influenza vaccination in heart failure: a shot worth taking? Free to access with registration until Sept 9, 2025 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01679-4/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_esc25&_hsenc=p2ANqtz-8m6bs5aoqmv5ojXQ3LcFXBZApsooIVQ9TWJXwvjOPtPw35v6jmY7HQBLW2omjTA1szAe86mNey6JDLr3ajNtD2iL0lUw&_hsmi=378460064&utm_content=378460064&utm_source=hs_email Vericiguat across the heart failure spectrum Free to access with registration until Sept 9, 2025 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01765-9/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_esc25&_hsenc=p2ANqtz-_69bXQO6Xlm9Gl1TBKIohz4rF19r582vdZygPEtwmSKxCuRonzL3LuV2tHvSTJgnXfba_Ptsz9akJLh7jB3PXd8qSlFA&_hsmi=378460064&utm_content=378460064&utm_source=hs_email Optional hypertension: a new concept emerging from trials of intensive blood pressure control Free to access with registration until Sept 9, 2025 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01670-8/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_esc25&_hsenc=p2ANqtz--acN63eM-ln22weWTjXvJvgj9L9BqBwolb1E2XY77nzIAHNYwcapNDHevdV4Q1OEraKTrRKKLYYDhviscrgyOT6uBM_Q&_hsmi=378460064&utm_content=378460064&utm_source=hs_email Paclitaxel in the lower limbs: harm outweighs the benefit Free to access with registration until Sept 9, 2025 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01684-8/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_esc25&_hsenc=p2ANqtz--rNOPfd3znwp4gzRcvNtqL6k4Ox8wzPZVqVA_W0RhLLdzpn8H06cyz_4_TznK5RqvPEXYb4ADz6Qjkr_qe2WimdusAXQ&_hsmi=378460064&utm_content=378460064&utm_source=hs_email Immediate or staged complete revascularisation in patients with ST segment elevation myocardial infarction Free to access with registration until Sept 9, 2025 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01680-0/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_esc25&_hsenc=p2ANqtz-9SlnW0lTRCjXYy1fSkHUUhRs4jFHoqoGW7po7PftzMR_L_y3hugwh_-K1U6jwyYnUNWgrStjl5PYd_8iwUPQAnoS8FQw&_hsmi=378460064&utm_content=378460064&utm_source=hs_email Evolocumab for prevention of coronary artery bypass failure: timing is everything Free to access with registration until Sept 9, 2025 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01718-0/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_esc25&_hsenc=p2ANqtz-_cnDhXmVbJ-sNad5RybF0vJKgWoeb3OYK_os6rjiYoc4UDhu7PkcPMMZCrqQZK8I_5DBmM5sZAWx-UQnLkFeyn_YJGNw&_hsmi=378460064&utm_content=378460064&utm_source=hs_email